FEATURED ARTICLES
What To Expect From An FDA Inspection
Former FDA inspector turned regulatory consultant, Patrick Stone, gives some valuable insights to what to expect when the FDA comes knocking at your clinical trial site. Here's a hint: make sure you PI knows the difference between presiding over and overseeing a study.
-
![doctor patient health plan-GettyImages-1357807788]( "Considering The Patient Experience Is Critical To Creating A Successful ICF")
Considering The Patient Experience Is Critical To Creating A Successful ICFIf an ICF is not written with the patient in mind — so that it truly facilitates an informed consent — a clinical trial runs the risk of losing viable study participants and derailing study start-up, even success.
-
![GettyImages-1329836000]( "How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials")
How To Determine Country Feasibility For Cell And Gene Therapy Clinical TrialsLearn how to choose the right location — globally — for your next cell and gene therapy clinical trial.
-
![diverse people-mixed reactions-GettyImages-1589930234]( "The Results Are In — Survey Reveals Barriers & Opportunities In Site Sustainability")
The Results Are In — Survey Reveals Barriers & Opportunities In Site SustainabilityGet a better understanding of site-level dynamics with 2024 release of the Society for Clinical Research Sites' (SCRS) Site Landscape Survey.
SERVICES & PRODUCTS
Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.
Delve into the details of this full-service global product development and strategic regulatory group that has a proven track record of successful FDA meetings and approvals.
Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
The hard truth is: Clinical Oversight is essential — and required. Ensuring that your trial is delivered with the highest of quality, on time, and on budget is essential with the escalating costs to conduct clinical trials and to avoid unnecessary and often required, change orders.
Gain insight into how inSeption Group’s Regional Site Managers (RSMs) are recapturing the importance of building relationships with clinical sites and acting as a “one-stop shop” for all activities related to clinical study sites.
Greenphire's EnvisiX solution is a budget build and negotiation tool that enables sponsors and CROs to effectively and efficiently build a study budget. The tool provides a streamlined and controlled workflow for budget negotiation for sponsors and CROs with complete transparency and management of rates, adjustments, adjudications, approvals and more.